Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP
Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The project was undertaking by Qilu Hospital of Shandong University and other 18 well-known
hospitals in China. In order to report the efficacy and safety of decitabine combining with
dexamethasone for the treatment of adults with immune thrombocytopenia (ITP), compared to
dexamethasone alone .
Phase:
Phase 3
Details
Lead Sponsor:
Shandong University
Collaborators:
Chinese Academy of Medical Sciences Qingdao Central Hospital Second Affiliated Hospital of Medical College Shandong University Shandong Provincial Hospital